Condition
Prognostic Stage IV Breast Cancer AJCC v8 clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Prognostic Stage IV Breast Cancer AJCC v8 clinical trials that are recruiting, at sites in 3 countries (most in United States (9), Guam (1), Puerto Rico (1)). By phase: Phase 2 (4), Phase 1 (2), Early Phase 1 (1). The most active sponsors are M.D. Anderson Cancer Center (3), Roswell Park Cancer Institute (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 3Countries
Newest Prognostic Stage IV Breast Cancer AJCC v8 clinical trials
All recruiting trials (9)
-
Personalized tumor vaccine with checkpoint inhibitors for triple negative breast cancer
This phase I trial will test whether a personalized tumor membrane vesicle (TMV) vaccine, given alone or with pembrolizumab or ipilimumab, can boost immune response and help control disease in adults with triple negative breast cancer.
-
Using minoxidil to treat hair loss in breast cancer patients on endocrine therapy
This study is testing if a hair loss treatment called minoxidil, given either as a foam or a pill, can help women with breast cancer who are losing their hair due to cancer therapy.
-
Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors
This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.
-
Avapritinib for treating advanced solid tumors with specific mutations
This study is testing if a new drug called avapritinib can help people with advanced solid tumors that have specific mutations feel better and live longer after other treatments haven't worked.
-
Investigating biomarkers and clinical features in metastatic breast cancer patients treated with CDK4/6 inhibitors
This study is trying to learn more about how metastatic breast cancer patients respond to CDK4/6 inhibitors by looking at their medical records and collecting blood and tissue samples to understand the cancer better.
-
Dendritic cell vaccines and pembrolizumab for treating brain metastasis from breast cancer
This study is testing a new vaccine combined with an immune therapy to see if it can help people with brain metastasis from triple negative or HER2+ breast cancer fight their cancer better.
-
Using abemaciclib to treat older patients with hormone receptor positive breast cancer
This study is testing if the medication abemaciclib can safely help older patients with hormone receptor positive breast cancer feel better and live longer.
-
Combining Olaparib with Cediranib or AZD6738 for Advanced Breast Cancer with BRCA Mutations
This study is testing if combining the drugs olaparib with either cediranib or AZD6738 can help women with advanced breast cancer that has BRCA mutations feel better after they’ve already tried other treatments.
-
Monitoring breast cancer using serum tumor markers
This study is testing if using blood tests to monitor hormone receptor positive, HER2 negative metastatic breast cancer can help patients live as long as those who receive standard monitoring while also looking at costs and how patients feel.
Related topics
Quick answers
How many Prognostic Stage IV Breast Cancer AJCC v8 clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (9 trials), Guam (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.